Rubric Capital Management L.P. is an investment fund managing more than $3.38 trillion ran by Michael Nachmani. There are currently 66 companies in Mr. Nachmani’s portfolio. The largest investments include Teva Pharmaceutical Inds Ltd and Viatris, together worth $470 billion.
As of 3rd May 2024, Rubric Capital Management L.P.’s top holding is 17,669,588 shares of Teva Pharmaceutical Inds Ltd currently worth over $249 billion and making up 7.4% of the portfolio value.
In addition, the fund holds 18,442,093 shares of Viatris worth $220 billion, whose value grew 28.8% in the past six months.
The third-largest holding is Roivant Sciences Ltd worth $211 billion and the next is Golar Lng worth $157 billion, with 6,506,757 shares owned.
Currently, Rubric Capital Management L.P.'s portfolio is worth at least $3.38 trillion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Rubric Capital Management L.P. office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Michael Nachmani serves as the Chief Operating Officer at Rubric Capital Management L.P..
In the most recent 13F filing, Rubric Capital Management L.P. revealed that it had opened a new position in
Ishares Bitcoin Tr and bought 1,722,497 shares worth $69.7 billion.
The investment fund also strengthened its position in Viatris by buying
5,192,093 additional shares.
This makes their stake in Viatris total 18,442,093 shares worth $220 billion.
Viatris soared 26.0% in the past year.
On the other hand, there are companies that Rubric Capital Management L.P. is getting rid of from its portfolio.
Rubric Capital Management L.P. closed its position in Cameco on 10th May 2024.
It sold the previously owned 2,523,540 shares for $100 billion.
Michael Nachmani also disclosed a decreased stake in Teva Pharmaceutical Inds Ltd by approximately 0.1%.
This leaves the value of the investment at $249 billion and 17,669,588 shares.
The two most similar investment funds to Rubric Capital Management L.P. are Amg National Trust Bank and Horizon Investments. They manage $3.38 trillion and $3.38 trillion respectively.
Rubric Capital Management L.P.’s portfolio is diversified across 9 sectors.
Currently, their heaviest sector is Health Care — making up 28.8% of
the total portfolio value.
The fund focuses on investments in the United States as
50.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
5% of the total holdings value.
On the other hand, large-cap stocks make up only 3.0% of the portfolio.
The average market cap of the portfolio companies is close to $2.09 billion.
These positions were updated on May 10th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
Security | Shares Owned | Value | Allocation |
---|---|---|---|
Teva Pharmaceutical Inds Ltd |
7.00%
17,669,588
|
$249,317,887,000 | 7.37% |
Viatris Inc. |
39.19%
18,442,093
|
$220,198,590,000 | 6.51% |
Roivant Sciences Ltd |
90.48%
20,000,000
|
$210,800,000,000 | 6.23% |
Golar Lng |
No change
6,506,757
|
$156,552,573,000 | 4.63% |
Bgc Group Inc |
5.00%
19,000,000
|
$147,630,000,000 | 4.37% |
Mr. Cooper Group Inc |
22.72%
1,518,773
|
$118,388,355,000 | 3.50% |
QuidelOrtho Corporation |
709.65%
2,400,000
|
$115,056,000,000 | 3.40% |
Fluor Corp New |
9.26%
2,600,000
|
$109,928,000,000 | 3.25% |
Cameco Corp. |
Closed
2,523,540
|
$100,033,126,000 | |
Vistra Corp |
101.60%
1,213,998
|
$84,554,961,000 | 2.50% |
Constellium SE |
85.76%
3,630,347
|
$80,266,972,000 | 2.37% |
Pactiv Evergreen Inc. |
10.83%
5,541,393
|
$79,352,748,000 | 2.35% |
Mativ Holdings Inc |
No change
4,000,000
|
$75,000,000,000 | 2.22% |
Arcutis Biotherapeutics Inc |
49.17%
7,510,000
|
$74,424,100,000 | 2.20% |
Heron Therapeutics Inc |
No change
26,713,503
|
$73,996,403,000 | 2.19% |
Collegium Pharmaceutical Inc |
42.24%
1,834,027
|
$71,196,928,000 | 2.11% |
Renew Energy Global Plc |
18.33%
11,711,700
|
$70,270,200,000 | 2.08% |
Ishares Bitcoin Tr |
Opened
1,722,497
|
$69,709,454,000 | 2.06% |
ANI Pharmaceuticals Inc |
13.17%
958,533
|
$66,263,386,000 | 1.96% |
Liberty Global Ltd |
Opened
5,738,644
|
$98,461,028,000 | 2.91% |
Hertz Global Holdings Inc. |
Closed
5,165,254
|
$63,274,362,000 | |
Dole plc |
37.39%
5,141,388
|
$61,336,759,000 | 1.81% |
Stratasys Ltd |
454.56%
5,050,000
|
$58,681,000,000 | 1.74% |
Amneal Pharmaceuticals Inc |
137.10%
9,541,948
|
$57,824,205,000 | 1.71% |
Ncr Voyix Corporation |
Opened
4,546,081
|
$57,417,003,000 | 1.70% |
Orthofix Med Inc |
6.71%
3,665,000
|
$53,215,800,000 | 1.57% |
NRG Energy Inc. |
Closed
1,318,020
|
$50,770,130,000 | |
Adeia Inc |
No change
4,640,009
|
$50,668,898,000 | 1.50% |
Xperi Inc |
No change
4,043,744
|
$48,767,553,000 | 1.44% |
Mereo BioPharma Group plc |
16.67%
13,552,997
|
$44,724,890,000 | 1.32% |
AAR Corp. |
40.98%
725,000
|
$43,405,750,000 | 1.28% |
Kiniksa Pharmaceuticals Ltd |
28.64%
2,196,009
|
$43,327,258,000 | 1.28% |
Playa Hotels & Resorts Nv |
20.01%
4,155,840
|
$40,311,648,000 | 1.19% |
Extreme Networks Inc. |
Opened
3,450,000
|
$39,813,000,000 | 1.18% |
Hollysys Automation Tchngy L |
Closed
1,941,237
|
$38,514,142,000 | |
Dave & Busters Entmt Inc |
Opened
598,503
|
$37,466,288,000 | 1.11% |
Zymeworks Inc |
31.08%
3,475,384
|
$36,561,040,000 | 1.08% |
Atmus Filtration Technologie |
Opened
1,132,056
|
$36,508,806,000 | 1.08% |
Adaptive Biotechnologies Cor |
Opened
10,500,000
|
$33,705,000,000 | 1.00% |
Koppers Holdings Inc |
49.70%
572,658
|
$31,593,542,000 | 0.93% |
Magnite Inc |
Closed
4,000,000
|
$30,160,000,000 | |
Transalta Corp. |
6.41%
4,687,158
|
$30,138,426,000 | 0.89% |
Par Pac Holdings Inc |
60.84%
772,384
|
$28,624,551,000 | 0.85% |
Cannae Holdings Inc |
Opened
1,214,217
|
$27,004,186,000 | 0.80% |
Schrodinger, Inc. |
Opened
998,276
|
$26,953,452,000 | 0.80% |
Avis Budget Group Inc |
Opened
215,092
|
$26,340,166,000 | 0.78% |
Coherus Biosciences Inc |
Opened
10,400,000
|
$24,856,000,000 | 0.73% |
Riskified Ltd. |
159.19%
4,173,636
|
$22,579,371,000 | 0.67% |
SpringWorks Therapeutics, Inc. |
Opened
426,768
|
$21,005,521,000 | 0.62% |
Ftai Infrastructure Inc |
No change
3,193,530
|
$20,055,368,000 | 0.59% |
Nuvalent Inc |
Opened
261,874
|
$19,664,119,000 | 0.58% |
Trevi Therapeutics, Inc. |
2.12%
5,564,123
|
$19,196,224,000 | 0.57% |
AdaptHealth Corp. |
Closed
1,961,199
|
$17,846,911,000 | |
scPharmaceuticals Inc |
29.92%
3,525,000
|
$17,695,500,000 | 0.52% |
Ovid Therapeutics Inc |
2.39%
5,315,969
|
$16,213,705,000 | 0.48% |
Omniab Inc |
No change
2,850,588
|
$15,450,187,000 | 0.46% |
GoodRx Holdings, Inc. |
Opened
2,117,054
|
$15,031,083,000 | 0.44% |
Madison Square Grdn Sprt Cor |
Closed
83,512
|
$14,723,166,000 | |
Pacira BioSciences Inc |
Closed
459,637
|
$14,101,663,000 | |
Ardelyx Inc |
27.34%
1,816,585
|
$13,261,071,000 | 0.39% |
Revance Therapeutics Inc |
66.05%
2,656,847
|
$13,071,687,000 | 0.39% |
Sutro Biopharma Inc |
Closed
3,344,810
|
$11,606,491,000 | |
Cullinan Oncology, LLC |
No change
626,929
|
$10,682,870,000 | 0.32% |
Clear Channel Outdoor Hldgs |
Closed
6,705,943
|
$10,595,390,000 | |
Werewolf Therapeutics Inc |
16.24%
1,621,034
|
$10,504,300,000 | 0.31% |
Pediatrix Medical Group Inc |
Opened
908,600
|
$9,113,258,000 | 0.27% |
Telesat Corp |
No change
959,764
|
$8,177,189,000 | 0.24% |
MagnaChip Semiconductor Corp |
Closed
967,867
|
$8,042,975,000 | |
Playstudios Inc |
20.78%
2,368,777
|
$6,585,200,000 | 0.19% |
Ars Pharmaceuticals Inc |
No change
639,203
|
$6,532,655,000 | 0.19% |
Opko Health Inc |
Opened
4,935,814
|
$5,922,977,000 | 0.18% |
Protagonist Therapeutics Inc |
Opened
198,059
|
$5,729,847,000 | 0.17% |
Carpenter Technology Corp. |
Opened
78,661
|
$5,617,969,000 | 0.17% |
Bicycle Therapeutics plc |
No change
205,423
|
$5,115,033,000 | 0.15% |
Conduent Inc |
Closed
834,660
|
$2,904,617,000 | |
TherapeuticsMD, Inc. |
No change
1,192,191
|
$2,730,117,000 | 0.08% |
Xeris Biopharma Holdings Inc |
Opened
310,959
|
$687,219,000 | 0.02% |
Vincerx Pharma Inc |
67.02%
116,873
|
$591,377,000 | 0.02% |
No transactions found | |||
Showing first 500 out of 78 holdings |